Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
pinaverium (pinaverium bromide)
Mylan Laboratories SAS
A03AX04
pinaverium (pinaverium bromide)
50mg
tablets film-coated
(20/1x20/) in blister
Prescription
Registered
2020-12-03
MASTER SUMMARY OF PRODUCT CHARACTERISTICS (SMPC) PINAVERIUM BROMIDE 1. NAME OF THE MEDICINAL PRODUCT Dicetel 50 mg &100 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: pinaverium bromide Each film-coated tablet contains 50 mg or 100 mg of pinaverium bromide. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM 50 mg Tablets Round biconvex tablets, film-coated orange, engraved "50" on one side and marked « Ñ » under the letter «S» on the other side. 100 mg Tablets Round biconvex tablets, film-coated orange, marked "100" on one side and marked « Ñ » under the letter «S» on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Symptomatic treatment of pain, transitory disorders and intestinal discomfort related to functional intestinal disturbances; - Symptomatic treatment of pain related to functional disturbances of the biliary tract; - Preparation for a barium enema. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY For oral use. Tablets taken with food whole without chewing or dissolving, with a glass of water to prevent contact pinaverium bromide with the mucosa of the esophagus (see. Section "Special Instructions"). Dicetel®, tablets, film-coated, 50 mg. The recommended daily dose - 1 tablet 3 times a day, or 2 tablets 2 times per day. If necessary, the daily dose may be increased to two tablets three times a day. In preparation for X-ray examination - 2 tablets 2 times a day for 3 days prior to the study. Dicetel ®, tablets, film-coated, 100 mg. The recommended daily dose - 1 tablet 2 times a day. If necessary, the daily dose may be increased to 1 tablet three times a day. In preparation for X-ray examination - 1 tablet 2 times a day for 3 days prior to the study. 4.3 CONTRAINDICATIONS - Hypersensitivity to any component of the formulation. - Lactase deficiency, galactose intolerance, glucose-galactose malabsorption. MASTER SUMMARY OF PRODUCT CHARACTERISTICS (SMPC) PINAVERIUM BROMIDE Due to the lack of data on the efficacy an Read the complete document